ArticleAntimicrobial agents and chemotherapy2003
Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States.
Article in Antimicrobial agents and chemotherapy, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Immuno-Informatics Design of Multi-Epitope Vaccine Candidate AgainstHealth science reports · 2026Article
- Trends in Anaplasmosis Over the Past Decade: A Review of Clinical Features, Laboratory Data, and Outcomes.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Distinct modes of cell division drivemBio · 2025Article
- Tick-Borne Bacterial Diseases in Europe: Threats to public health.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024Review
- Epidemiological, clinical, and laboratory characteristics of human granulocytic anaplasmosis in North India.Journal of clinical microbiology · 2024Article
- A Quantum Vaccinomics Approach for the Design and Production of MSP4 Chimeric Antigen for the Control ofVaccines · 2022Article
- Article
- Article
- Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome.Microorganisms · 2021Article
- Review
- Co-Infection of Scrub Typhus and Human Granulocytic Anaplasmosis in Korea, 2006.Journal of Korean medical science · 2019Article
- Human metallo-β-lactamase enzymes degrade penicillin.Scientific reports · 2019Article
- Article
- Human granulocytic anaplasmosis.Infectious disease clinics of North America · 2015Review
- Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe.Parasites & vectors · 2015Review
- Anaplasma phagocytophilum infection in a domestic cat in Finland: Case report.Acta veterinaria Scandinavica · 2010Article
- Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis.Expert review of anti-infective therapy · 2009Review
- Inclusion bodies in tick-borne diseases diagnosed in patients from northern Wisconsin.Clinical medicine & research · 2009Article
- Coinfections acquired from ixodes ticks.Clinical microbiology reviews · 2006Review
- Tick-borne infections in children: epidemiology, clinical manifestations, and optimal management strategies.Paediatric drugs · 2005Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We tested the antibiotic susceptibilities of eight strains of Anaplasma phagocytophilum (the agent of human granulocytic ehrlichiosis) collected in various geographic areas of the United States, including Minnesota, Wisconsin, California, and New York. The results are homogeneous and show that doxycycline, rifampin, and levofloxacin are the most active antibiotics against these strains in vitro.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.